Compounds > dideoxyadenosine
Page last updated: 2024-08-22

dideoxyadenosine and 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside

dideoxyadenosine has been researched along with 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Balzarini, J; Dalley, NK; De Clercq, E; Herdewijn, P; Robins, MJ; Wood, SG1
Balzarini, J; De Clercq, E1
Baba, M; Balzarini, J; de Clercq, E; Herdewijn, P; Pauwels, R; Robins, MJ; Wood, SG1
Harada, Y; Liu, X; Mizushina, Y; Ogawara, T; Ogimura, Y; Saneyoshi, M; Takahashi, H; Yamaguchi, T1
Inomata, M; Liu, X; Ogawara, T; Saneyoshi, M; Yamaguchi, T1

Other Studies

5 other study(ies) available for dideoxyadenosine and 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside

ArticleYear
Nucleic acid related compounds. 57. Synthesis, x-ray crystal structure, lipophilic partition properties, and antiretroviral activities of anomeric 3'-azido-2',3'-dideoxy-2,6-diaminopurine ribosides.
    Journal of medicinal chemistry, 1989, Volume: 32, Issue:8

    Topics: Animals; Antiviral Agents; Cell Transformation, Viral; Chemical Phenomena; Chemistry; Dideoxyadenosine; Dideoxynucleosides; Mice; Microbial Sensitivity Tests; Models, Molecular; Retroviridae; Solubility; X-Ray Diffraction

1989
The antiviral activity of 9-beta-D-arabinofuranosyladenine is enhanced by the 2',3'-dideoxyriboside, the 2',3'-didehydro-2',3'-dideoxyriboside and the 3'-azido-2',3'-dideoxyriboside of 2,6-diaminopurine.
    Biochemical and biophysical research communications, 1989, Feb-28, Volume: 159, Issue:1

    Topics: Dideoxyadenosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Synergism; Simplexvirus; Vaccinia virus; Vidarabine; Viral Plaque Assay

1989
Potent and selective activity of 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside, 3'-fluoro-2,6-diaminopurine-2',3'-dideoxyriboside, and 3'-fluoro-2',3'-dideoxyguanosine against human immunodeficiency virus.
    Molecular pharmacology, 1988, Volume: 33, Issue:3

    Topics: Adenosine Deaminase; Antimetabolites; Antiviral Agents; Coformycin; Deoxyadenosines; Deoxyguanosine; Dideoxyadenosine; Dideoxynucleosides; HIV; Pentostatin; Prodrugs; Solubility; Virus Replication

1988
3'-Azido-2',3'-dideoxynucleoside 5'-triphosphates inhibit telomerase activity in vitro, and the corresponding nucleosides cause telomere shortening in human HL60 cells.
    Nucleic acids research, 2007, Volume: 35, Issue:21

    Topics: Antineoplastic Agents; Cell Proliferation; Dideoxyadenosine; Dideoxynucleosides; Dideoxynucleotides; DNA; Enzyme Inhibitors; HeLa Cells; HL-60 Cells; Humans; Telomerase; Telomere; Zidovudine

2007
Telomere shortening in human HL60 cells by treatment with 3'-azido-2',3'-dideoxynucleosides and telomerase inhibition by their 5'-triphosphates.
    Nucleosides, nucleotides & nucleic acids, 2007, Volume: 26, Issue:8-9

    Topics: Dideoxyadenosine; Dideoxynucleosides; Dideoxynucleotides; Drug Design; Enzyme Inhibitors; HL-60 Cells; Humans; Telomerase; Telomere

2007